Ultra-small polydopamine nanomedicine-enabled antioxidation against senescence
Source abstract
Abstract
Senescence is a cellular response characterized by cells irreversibly stopping dividing and entering a state of permanent growth arrest. One of the underlying pathophysiological causes of senescence is the oxidative stress-induced damage, indicating that eliminating the reactive oxygen and nitrogen species (RONS) may be beneficial to prevent and/or alleviate senescence. Herein, we developed ultra-small polydopamine nanoparticles (UPDA NPs) with superoxide dismutase (SOD)/catalase (CAT) enzyme-mimic activities, featuring broad-spectrum RONS-scavenging capability for inducing cytoprotective effects against RONS-mediated damage. The engineered UPDA NPs can restore senescence-related renal function, tissue homeostasis, fur density, and motor ability in mice, potentially associated with the regulation of multiple genes involved in lipid metabolism, mitochondrial function, energy homeostasis, telomerase activity, neuroprotection, and inflammatory responses. Importantly, the dietary UPDA NPs can enhance the antioxidant capacity, improve the climbing ability, and prolong the lifespan of Drosophila. Notably, UPDA NPs possess excellent biocompatibility stemming from the ultra-small size, ensuring quick clearance out of the body. These findings reveal that UPDA NPs can delay aging through reducing oxidative stress and provide a paradigm and practical strategy for treating senescence and senescence-related diseases.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Advanced Nanomaterials in Catalysis · Carbon and Quantum Dots Applications · Nanocluster Synthesis and Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (80)
Show source-provided references
1. The metabolic roots of senescence: mechanisms and opportunities for intervention10.1038/s42255-021-00483-8 ↗
2. Disease-associated astrocytes in Alzheimer's disease and aging10.1038/s41593-020-0624-8 ↗
3. Rates of complications and mortality in older patients with diabetes mellitus the diabetes and aging study10.1001/jamainternmed.2013.12956 ↗
4. Senescent cells: an emerging target for diseases of ageing10.1038/nrd.2017.116 ↗
5. Analysis of cancer genomes reveals basic features of human aging and its role in cancer development10.1038/ncomms12157 ↗
6. The hallmarks of aging10.1016/j.cell.2013.05.039 ↗
7. Mechanisms of cellular senescence: cell cycle arrest and senescence associated secretory phenotype10.3389/fcell.2021.645593 ↗
8. Dynamic-reversible photoacoustic probe for continuous ratiometric sensing and imaging of redox status in vivo10.1021/jacs.9b10353 ↗
9. Homologous-targeted and tumor microenvironment-activated hydroxyl radical nanogenerator for enhanced chemoimmunotherapy of non-small cell lung cancer10.1016/j.cej.2021.131451 ↗
10. Redox-active radical scavenging nanomaterials10.1039/b919677n ↗
11. Targeting oxidative stress in disease: promise and limitations of antioxidant therapy (Jun, 10.1038/s41573-021-00233-1, 2021)10.1038/s41573-021-00267-5 ↗
12. The critical role of catalase in prooxidant and antioxidant function of p5310.1038/cdd.2012.102 ↗
13. Superoxide dismutase 1 acts as a nuclear transcription factor to regulate oxidative stress resistance10.1038/ncomms4446 ↗
14. Parallel molecular mechanisms for enzyme temperature adaptation10.1126/science.aay2784 ↗
15. Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes10.1039/c3cs35486e ↗
16. Effect of antioxidant mineral elements supplementation in the treatment of hypertension in albino rats10.1155/2012/134723 ↗
17. And medmaterial10.15541/jim20220194 ↗
18. Bioinspired copper single-atom catalysts for tumor parallel catalytic therapy10.1002/adma.202002246 ↗
19. Catalytic activity tunable ceria nanoparticles prevent chemotherapy-induced acute kidney injury without interference with chemotherapeutics10.1038/s41467-021-21714-2 ↗
20. In vitro free radical scavenging activity of platinum nanoparticles10.1088/0957-4484/20/45/455105 ↗
21. An antioxidant nanozyme that uncovers the cytoprotective potential of vanadia nanowires10.1038/ncomms6301 ↗
22. 2D vanadium carbide MXenzyme to alleviate ROS-mediated inflammatory and neurodegenerative diseases
23. Pharmacokinetics and preventive effects of platinum nanoparticles as reactive oxygen species scavengers on hepatic ischemia/reperfusion injury in mice10.1039/C4MT00018H ↗
24. Mitochondria-targeting ceria nanoparticles as antioxidants for Alzheimer's disease10.1021/acsnano.5b08045 ↗
25. Ceria nanoparticle systems for selective scavenging of mitochondrial, intracellular, and extracellular reactive oxygen species in Parkinson's disease10.1002/anie.201805052 ↗
26. Molybdenum-based nanoclusters act as antioxidants and ameliorate acute kidney injury in mice10.1038/s41467-018-07890-8 ↗
27. Rational design and biological application of antioxidant nanozymes10.3389/fchem.2020.00831 ↗
28. In vivo guiding nitrogen-doped carbon nanozyme for tumor catalytic therapy10.1038/s41467-018-03903-8 ↗
29. Renal-clearable ultrasmall polypyrrole nanoparticles with size-regulated property for second near-infrared light-mediated photothermal therapy10.1002/adfm.202008362 ↗
30. Advances in organometallic/organic nanozymes and their applications10.1016/j.ccr.2020.213652 ↗
31. Artificial melanin particles: new building blocks for biomimetic structural coloration10.1038/s41428-019-0231-2 ↗
32. Role of polydopamine's redox-activity on its pro-oxidant, radical-scavenging, and antimicrobial activities10.1016/j.actbio.2019.02.032 ↗
33. Polydopamine nanoparticles as efficient scavengers for reactive oxygen species in periodontal disease10.1021/acsnano.8b04022 ↗
34. Polydopamine nanoparticles for the treatment of acute inflammation-induced injury10.1039/C8NR00838H ↗
35. Ultrasmall copper-based nanoparticles for reactive oxygen species scavenging and alleviation of inflammation related diseases
36. Glomerular barrier behaves as an atomically precise bandpass filter in a sub-nanometre regime10.1038/nnano.2017.170 ↗
37. Highly efficient lead(II) sequestration using size-controllable polydopamine microspheres with superior application capability and rapid capture10.1021/acssuschemeng.7b00129 ↗
38. Multi-enzyme mimetic ultrasmall iridium nanozymes as reactive oxygen/nitrogen species scavengers for acute kidney injury management10.1016/j.biomaterials.2021.120706 ↗
39. Dual effects of curcumin on neuronal oxidative stress in the presence of Cu(II)10.1016/j.fct.2011.04.004 ↗
40. Mitochondrial protein-linked DNA breaks perturb mitochondrial gene transcription and trigger free radical-induced DNA damage10.1126/sciadv.1602506 ↗
41. Piezocatalytic tumor therapy by ultrasound-triggered and BaTiO3-mediated piezoelectricity10.1002/adma.202001976 ↗
42. Limiting oxidative DNA damage reduces microbe-induced colitis-associated colorectal cancer10.1038/s41467-020-15549-6 ↗
43. PIDD-dependent activation of caspase-2-mediated mitochondrial injury in E1A-induced cellular sensitivity to macrophage nitric oxide-induced apoptosis
44. Exogenous nitric oxide stimulates the odontogenic differentiation of rat dental pulp stem cells
45. Estimation of antioxidant capacity against pathophysiologically relevant oxidants using Pyrogallol Red10.1016/j.bbrc.2009.10.023 ↗
46. Polydopamine and eumelanin molecular structures investigated with ab initio calculations10.1039/C6SC04692D ↗
47. Atypical structural and pi-electron features of a melanin polymer that lead to superior free-radical-scavenging properties10.1002/anie.201305747 ↗
48. The supramolecular structure of melanin10.1039/b902507c ↗
49. Spectroelectrochemical reverse engineering demonstrates that melanin's redox and radical scavenging activities are linked10.1021/acs.biomac.7b01166 ↗
50. ROS scavenging biopolymers for anti-inflammatory diseases: classification and formulation10.1002/admi.202000632 ↗
51. Targeted apoptosis of senescent cells restores tissue homeostasis in response to chemotoxicity and aging10.1016/j.cell.2017.02.031 ↗
52. Chitosan-decorated doxorubicin-encapsulated nanoparticle targets and eliminates tumor reinitiating cancer stem-like cells10.1021/nn506928p ↗
53. Cacao powder supplementation attenuates oxidative stress, cholinergic impairment, and apoptosis in d-galactose-induced aging rat brain
54. Senescence-associated beta-galactosidase is lysosomal beta-galactosidase10.1111/j.1474-9726.2006.00199.x ↗
55. Cells exhibiting strong p16 (INK4a) promoter activation in vivo display features of senescence10.1073/pnas.1818313116 ↗
56. p16(Ink4a)-induced senescence of pancreatic beta cells enhances insulin secretion10.1038/nm.4054 ↗
57. Upregulation of the p53-p21 pathway by G2019S LRRK2 contributes to the cellular senescence and accumulation of alpha-synuclein10.1080/15384101.2019.1577666 ↗
58. Decoy receptor 2 mediation of the senescent phenotype of tubular cells by interacting with peroxiredoxin 1 presents a novel mechanism of renal fibrosis in diabetic nephropathy10.1016/j.kint.2022.10.006 ↗
59. Regulation of cellular senescence via the FOXO4-p53 axis10.1002/1873-3468.13057 ↗
60. Consequences of lamin B1 and lamin B receptor downregulation in senescence
61. Lamin B1 loss is a senescence-associated biomarker10.1091/mbc.e11-10-0884 ↗
62. Apolipoprotein D takes center stage in the stress response of the aging and degenerative brain10.1016/j.neurobiolaging.2014.01.148 ↗
63. Brown and beige adipose tissue and aging10.3389/fendo.2019.00368 ↗
64. Mitochondrial uncoupling protein 1 antagonizes atherosclerosis by blocking NLRP3 inflammasome-dependent interleukin-1 beta production10.1126/sciadv.abl4024 ↗
65. Mitochondrial uncoupling, ROS generation and cardioprotection10.1016/j.bbabio.2018.05.019 ↗
66. Transient induction of telomerase expression mediates senescence and reduces tumorigenesis in primary fibroblasts10.1073/pnas.1907199116 ↗
67. Antioxidant effect of leptin on neurogenic niches in a model of Alzheimer's disease10.1016/j.freeradbiomed.2016.10.416 ↗
68. The role of BDNF on aging-modulation markers10.3390/brainsci10050285 ↗
69. BDNF reverses aging-related microglial activation10.1186/s12974-020-01887-1 ↗
70. Emerging role of NF-kappa B signaling in the induction of senescence-associated secretory phenotype (SASP)10.1016/j.cellsig.2011.12.006 ↗
71. RAGE silencing ameliorates neuroinflammation by inhibition of p38-NF-kappa B signaling pathway in mouse model of Parkinson's disease
72. CCN2 enhances RANKL-induced osteoclast differentiation via direct binding to RANK and OPG10.1016/j.bone.2014.12.058 ↗
73. IL-6 in inflammation, autoimmunity and cancer10.1093/intimm/dxaa078 ↗
74. Drp1-mediated mitochondrial fission promotes cell proliferation through crosstalk of p53 and NF-kappa B pathways in hepatocellular carcinoma10.18632/oncotarget.11339 ↗
75. Gold nanoparticles using ecklonia stolonifera protect human dermal fibroblasts from UVA-induced senescence through inhibiting MMP-1 and MMP-310.3390/md18090433 ↗
76. p16(INK4a) induces differentiation and apoptosis in erythroid lineage cells10.1016/S0301-472X(03)00040-7 ↗
77. Interleukin-1 beta induction of neuron apoptosis depends on p38 mitogen-activated protein kinase activity after spinal cord injury10.1111/j.1745-7254.2005.00152.x ↗
78. Senescence-accelerated mouse (SAM): a novel murine model of senescence10.1016/S0531-5565(96)00036-8 ↗
79. Progressive vascular smooth muscle cell defects in a mouse model of Hutchinson-Gilford progeria syndrome10.1073/pnas.0600012103 ↗
80. Genetic mouse models of brain ageing and Alzheimer's disease10.1016/j.pharmthera.2013.12.009 ↗